Clover Health initiated with a Buy at Deutsche Bank
Buy
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Buy
What happened, with direct paths to the underlying reporting
Deutsche Bank initiated CLOV with a Buy rating and a $6 target. Current price: $4.34. Price since signal: +9.1%.
Target: $6
Posted price: $4.34
Analyst firm: Deutsche Bank
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.